Inventor · disambiguated record
Mustapha Haddach
Also filed as: HADDACH MUSTAPHA
34 granted patents·28 pending applications·266 citations·filing 1998–2024
97Inventor score
Files withNEUROCRINE BIOSCIENCES INC18PIMERA INC12CYLENE PHARMACEUTICALS INC7HADDACH MUSTAPHA7HUTCHINSON JOHN H4
Top patents by PatentIndex Score
62 records- 0196US9951066B2Compositions, uses and methods for making themPIMERA INC·Filed 2017·Granted Apr 24, 2018·8 cites·18 claims
- 0295US9758518B2Compositions, uses and methods for making themPIMERA INC·Filed 2015·Granted Sep 12, 2017·8 cites·10 claims
- 0395US7928100B2Quinolone analogs and methods related theretoCYLENE PHARMACEUTICALS INC·Filed 2008·Granted Apr 19, 2011·23 cites·2 claims
- 0491US10590134B2Compositions, uses and methods for making themPIMERA INC·Filed 2017·Granted Mar 17, 2020·3 cites·7 claims
- 0591US6583143B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Jun 24, 2003·35 cites·18 claims
- 0690US6531475B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2000·Granted Mar 11, 2003·38 cites·44 claims
- 0789US10745403B2Compositions, uses and methods for making themPIMERA INC·Filed 2019·Granted Aug 18, 2020·4 cites·12 claims
- 0888US9512123B2Compositions, uses and methods for making themPIMERA INC·Filed 2015·Granted Dec 6, 2016·8 cites·5 claims
- 0988US7977359B25-lipdxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2006·Granted Jul 12, 2011·11 cites·12 claims
- 1086US8168651B2Protein kinase modulatorsCHUA PETER C·Filed 2009·Granted May 1, 2012·11 cites·11 claims
- 1184US10442801B2Compositions, uses and methods for making themPIMERA INC·Filed 2018·Granted Oct 15, 2019·1 cites·16 claims
- 1284US8853234B2Quinolone analogs and methods related theretoNAGASAWA JOHNNY YASUO·Filed 2011·Granted Oct 7, 2014·13 cites·18 claims
- 1384US8575177B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsHADDACH MUSTAPHA·Filed 2010·Granted Nov 5, 2013·12 cites·40 claims
- 1483US8399666B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Mar 19, 2013·10 cites·5 claims
- 1582US9303033B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsSENHWA BIOSCIENCES INC·Filed 2013·Granted Apr 5, 2016·6 cites·44 claims
- 1679US10975076B2Compositions, uses and methods for making themPIMERA INC·Filed 2016·Granted Apr 13, 2021·1 cites·10 claims
- 1779US6610678B2CRF antagonistic quino-and quinazolinesFiled 2002·Granted Aug 26, 2003·11 cites·13 claims
- 1878US7973079B2Methods and compounds for treating retinol-related diseasesREVISION THERAPEUTICS INC·Filed 2008·Granted Jul 5, 2011·9 cites·10 claims
- 1977US11866438B2Compositions, uses and methods for making themPIMERA INC·Filed 2021·Granted Jan 9, 2024·0 cites·9 claims
- 2075US11623928B2Compositions, uses and methods for making themPIMERA INC·Filed 2020·Granted Apr 11, 2023·0 cites·6 claims
- 2175US8367681B2Pyrazolopyrimidines and related heterocycles as kinase inhibitorsCYLENE PHARMACEUTICALS INC·Filed 2010·Granted Feb 5, 2013·3 cites·13 claims
- 2274US11618752B2Compositions, uses and methods for making themPIMERA INC·Filed 2020·Granted Apr 4, 2023·0 cites·1 claims
- 2373US6723721B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Apr 20, 2004·5 cites·35 claims
- 2472US6747034B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Jun 8, 2004·5 cites·31 claims
- 2571US8841295B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Sep 23, 2014·1 cites·16 claims
- 2671US6541469B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Apr 1, 2003·4 cites·15 claims
- 2770US6500839B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Dec 31, 2002·4 cites·23 claims
- 2865US2025243200A1Crystal forms of a pol1 inhibitorPIMERA INC·Filed 2024·Application pending·0 cites
- 2963US11912706B2Crystal forms of a POL1 inhibitorPIMERA INC·Filed 2018·Granted Feb 27, 2024·0 cites·8 claims
- 3061US6514982B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Feb 4, 2003·19 cites·32 claims
- 3161US6440960B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Aug 27, 2002·3 cites·22 claims
- 3260US8124649B2Oxindole compoundsHADDACH MUSTAPHA·Filed 2009·Granted Feb 28, 2012·0 cites·21 claims
- 3355US2004229879A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 3453US2004157851A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 3553US2004121998A1CRF antagonistic quino- and quinazolinesNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 3652US2004266799A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 3751US7910600B2Therapeutic kinase modulatorsCYLENE PHARMACEUTICALS INC·Filed 2008·Granted Mar 22, 2011·0 cites·17 claims
- 3851US2004087589A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 3951US2008233606A1Use of raman spectroscopy in enzyme activity assaysHADDACH MUSTAPHA·Filed 2008·Application pending·0 cites
- 4050US2004014747A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 4149US6348466B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Feb 19, 2002·6 cites·18 claims
- 4249US2011065687A1Hydrazide compounds and uses thereofSCHWAEBE MICHAEL·Filed 2008·Application pending·0 cites
- 4349US2003153563A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2002·Application pending·0 cites
- 4449US2003130283A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2002·Application pending·0 cites
- 4549US2008318938A1Methods for treating aberrant cell proliferation disordersRYCKMAN DAVID M·Filed 2008·Application pending·0 cites
- 4648US2011118315A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN H·Filed 2011·Application pending·0 cites
- 4746US2012190669A1Oxindole compoundsHADDACH MUSTAPHA·Filed 2012·Application pending·0 cites
- 4846US2012208792A1Protein kinase modulatorsCHUA PETER C·Filed 2011·Application pending·0 cites
- 4945US2010068301A1Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulatorsHUTCHINSON JOHN H·Filed 2007·Application pending·0 cites
- 5045US2007219206A15-lipoxygenase-activating protein (flap) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mustapha Haddach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →